Pharmaceuticals, Biotechnology and Life Sciences
EMERYVILLE, Calif.–(BUSINESS WIRE)–Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today…
4-Hydroxynonenal (4-HNE) levels strongly correlate with rate of Amyotrophic Lateral Sclerosis (ALS) disease progression and survival of patients from onset…
Key Hires in CMC/Technical Operations, Business Development, and Finance MALVERN, Pa.–(BUSINESS WIRE)–Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on…
Dr. Clackson is a biotech veteran who brings 30 years of executive leadership, R&D, and commercialization experience in precision oncology…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biomedicalengineering—Pearl Bio (a synthetic biology company backed by Khosla Ventures) today announced that it has entered a license,…
Integration capabilities deliver real-time, disease-specific insights to healthcare providers to improve patient care and outcomes SAN FRANCISCO–(BUSINESS WIRE)–#ai–Viz.ai, the leader…
MENLO PARK, Calif.–(BUSINESS WIRE)–Sofinnova Investments, a healthcare investment firm, announced today the appointment of Troy Ignelzi to the investment team…
TOKYO–(BUSINESS WIRE)–Mitsubishi Corporation Life Sciences Limited (Head Office: Chiyoda-ku, Tokyo Japan; Koji Kishimoto, representative director and president) conducted the clinical…
BOSTON–(BUSINESS WIRE)–Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”), a biotechnology company that designs and develops breakthrough medicines for patients through…
DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical R&D Directory 2024” has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical R&D Directory provides a…